Chapter 1. Research Background
1.1 Research Objectives
1.2 Market Definition
1.3 Analysis Period
1.4 Market Data Reporting Unit
1.4.1 Value
1.5 Market Size Breakdown by Segment
1.5.1 Market Segmentation by Product Type
1.5.2 Market Segmentation by Application
1.5.3 Market Segmentation by End User
1.5.4 Market Segmentation by Usage Area
1.5.5 Market Segmentation by Region
1.6 Key Stakeholders
Chapter 2. Research Methodology
2.1 Secondary Research
2.1.1 Paid
2.1.2 Unpaid
2.1.3 P&S Intelligence Database
2.2 Primary Research
2.2.1 Breakdown of Primary Research, by Region
2.2.2 Breakdown of Primary Research, by Industry Participant
2.2.3 Breakdown of Primary Research, by Designation
2.2.4 Breakdown of Primary Research, by Company Type
2.3 Market Size Estimation
2.4 Data Triangulation
2.5 Currency Conversion Rates
2.6 Notes and Caveats
Chapter 3. Executive Summary
Chapter 4. Voice of Industry Experts/KOLs
Chapter 5. Market Indicators
5.1 Expanding Scope of DNA Sequencing
5.2 NGS in Clinical Oncology to Advance Personalized Treatment of Cancer
5.3 Burden of Cancer
Chapter 6. Definition of Market Segments
6.1 By Product Type
6.1.1 Consumables
6.1.1.1 Library preparation kits
6.1.1.2 Sample purification kits
6.1.1.3 Sample extraction and isolation kits
6.1.1.4 Target enrichment
6.1.1.5 Cleanup and selection kits
6.1.1.6 Microbiome DNA enrichment
6.1.1.7 Others
6.1.2 Standalone Automated Instruments
6.1.2.1 Fragment analyzers
6.1.2.2 Nucleic acid extraction/isolation systems
6.1.2.3 DNA selection instruments
6.1.2.4 DNA/RNA shearing instruments
6.1.2.5 Template preparation instruments
6.1.2.6 Ultrasonicators/sonicators
6.2 By Application
6.2.1 DNA Sequencing
6.2.2 Whole Genome Sequencing
6.2.3 RNA Sequencing
6.2.4 Methylation Sequencing
6.2.5 Others
6.3 By End User
6.3.1 Hospitals and Clinics
6.3.2 Academic and Research Institutes
6.3.3 Pharmaceutical and Biotechnology Companies
6.3.4 Other End Users
6.4 By Usage Area
6.4.1 Oncology
6.4.2 NIPT
6.4.3 Drug Discovery
6.4.4 Microbiology
6.4.5 Infectious Diseases
6.4.6 Germline Disease Risk Evaluation
6.4.7 Applied Markets
Chapter 7. Industry Outlook
7.1 Global NGS Sample Preparation Market Dynamics
7.1.1 Trends
7.1.1.1 Partnerships are key to strengthening global health systems
7.1.1.2 Customized automated NGS sample preparation platforms are preferred
7.1.2 Drivers
7.1.2.1 Emerging technologies empowering NGS of DNA
7.1.2.2 Massive growth in the life sciences and healthcare industries
7.1.3 Impact Analysis of Drivers on Market Forecast
7.1.4 Restraints
7.1.4.1 Stringent regulatory standards
7.1.4.2 High costs of NGS sample preparation instruments
7.1.5 Impact Analysis of Restraints on Market Forecast
7.2 Global Targeted DNA Sequencing Market Dynamics
7.2.1 Drivers
7.2.1.1 Increasing research on NGS and its applications
7.2.1.2 Launch of advanced targeted DNA/RNA sequencing products
7.3 U.S. Targeted DNA Sequencing Market Dynamics
7.3.1 Drivers
7.3.1.1 Rising demand for personalized medicine pharmacotherapy
7.3.1.2 Grants from government bodies for targeted sequencing studies
7.4 Global Targeted Methylation Sequencing Market Dynamics
7.4.1 Drivers
7.4.1.1 Increasing usage of biomarkers for early cancer detection and prognosis
7.4.1.2 Increasing Rising usage of targeted DNA methylation sequencing in epigenetic drug discovery
7.5 U.S. Targeted Methylation Sequencing Market Dynamics
7.5.1 Drivers
7.5.1.1 Proliferating research in diagnostics
7.6 Impact of Covid-19
7.7 Porter’s Five Forces Analysis
7.7.1 Bargaining Power of Buyers
7.7.2 Bargaining Power of Suppliers
7.7.3 Intensity of Rivalry
7.7.4 Threat of New Entrants
7.7.5 Threat of Substitutes
Chapter 8. Global Market Size and Forecast
8.1 Overview
8.2 Market Revenue, by Product Type (2019–2030)
8.2.1 Consumables Market, by Type
8.2.2 Standalone Automated Instruments Market, by Type
8.3 Market Revenue, by Application (2019–2030)
8.4 Market Revenue, by End User (2019–2030)
8.5 Market Revenue, by Usage Area (2019–2030)
8.6 Market Revenue, by Region (2019–2030)
Chapter 9. North America Market Size and Forecast
9.1 Overview
9.2 Market Revenue, by Product Type (2019–2030)
9.2.1 Consumables Market, by Type
9.2.2 Standalone Automated Instruments Market, by Type
9.3 Market Revenue, by Application (2019–2030)
9.4 Market Revenue, by End User (2019–2030)
9.5 Market Revenue, by Usage Area (2019–2030)
9.6 Market Revenue, by Country (2019–2030)
Chapter 10. Europe Market Size and Forecast
10.1 Overview
10.2 Market Revenue, by Product Type (2019–2030)
10.2.1 Consumables Market, by Type
10.2.2 Standalone Automated Instruments Market, by Type
10.3 Market Revenue, by Application (2019–2030)
10.4 Market Revenue, by End User (2019–2030)
10.5 Market Revenue, by Usage Area (2019–2030)
10.6 Market Revenue, by Country (2019–2030)
Chapter 11. APAC Market Size and Forecast
11.1 Overview
11.2 Market Revenue, by Product Type (2019–2030)
11.2.1 Consumables Market, by Type
11.2.2 Standalone Automated Instruments Market, by Type
11.3 Market Revenue, by Application (2019–2030)
11.4 Market Revenue, by End User (2019–2030)
11.5 Market Revenue, by Usage Area (2019–2030)
11.6 Market Revenue, by Country (2019–2030)
Chapter 12. LATAM Market Size and Forecast
12.1 Overview
12.2 Market Revenue, by Product Type (2019–2030)
12.2.1 Consumables Market, by Type
12.2.2 Standalone Automated Instruments Market, by Type
12.3 Market Revenue, by Application (2019–2030)
12.4 Market Revenue, by End User (2019–2030)
12.5 Market Revenue, by Usage Area (2019–2030)
12.6 Market Revenue, by Country (2019–2030)
Chapter 13. MEA Market Size and Forecast
13.1 Overview
13.2 Market Revenue, by Product Type (2019–2030)
13.2.1 Consumables Market, by Type
13.2.2 Standalone Automated Instruments Market, by Type
13.3 Market Revenue, by Application (2019–2030)
13.4 Market Revenue, by End User (2019–2030)
13.5 Market Revenue, by Usage Area (2019–2030)
13.6 Market Revenue, by Country (2019–2030)
Chapter 14. Competitive Landscape
14.1 Key Players
14.1.1 Illumina Inc.
14.1.2 Agilent Technologies Inc.
14.1.3 Thermo Fisher Scientific Inc.
14.1.4 ArcherDX Inc.
14.1.5 Twist Bioscience Corporation
14.1.6 Integrated DNA Technologies Inc.
14.1.7 Swift Biosciences Inc.
14.1.8 F. Hoffmann-La Roche Ltd.
14.2 Recent Strategic Developments of Key Players
14.2.1 Partnerships & Collaborations
14.2.2 Product Launches
14.2.3 Mergers & Acquisitions
14.2.4 Other Developments
Chapter 15. Company Profiles
15.1 Illumina Inc.
15.1.1 Business Overview
15.1.2 Product and Service Offerings
15.1.3 Key Financial Summary
15.2 Thermo Fisher Scientific Inc.
15.2.1 Business Overview
15.2.2 Product and Service Offerings
15.2.3 Key Financial Summary
15.3 F. Hoffmann-La Roche Ltd.
15.3.1 Business Overview
15.3.2 Product and Service Offerings
15.3.3 Key Financial Summary
15.4 ArcherDX Inc.
15.4.1 Business Overview
15.4.2 Product and Service Offerings
15.5 Pacific Biosciences of California Inc.
15.5.1 Business Overview
15.5.2 Product and Service Offerings
15.5.3 Key Financial Summary
15.6 Integrated DNA Technologies Inc.
15.6.1 Business Overview
15.6.2 Product and Service Offerings
15.7 Becton, Dickinson and Company
15.7.1 Business Overview
15.7.2 Product and Service Offerings
15.7.3 Key Financial Summary
15.8 Twist Bioscience Corporation
15.8.1 Business Overview
15.8.2 Product and Service Offerings
15.8.3 Key Financial Summary
15.9 QIAGEN N.V.
15.9.1 Business Overview
15.9.2 Product and Service Offerings
15.9.3 Key Financial Summary
15.10 Beckman Coulter Inc.
15.10.1 Business Overview
15.10.2 Product and Service Offerings
15.11 Agilent Technologies Inc.
15.11.1 Business Overview
15.11.2 Product and Service Offerings
15.11.3 Key Financial Summary
15.12 New England Biolabs Inc.
15.12.1 Business Overview
15.12.2 Product and Service Offerings
15.13 Danaher Corporation
15.13.1 Business Overview
15.13.2 Product and Service Offerings
15.14 Oxford Nanopore Technologies plc
15.14.1 Business Overview
15.14.2 Product and Service Offerings
15.15 Bio-Rad Laboratories Inc.
15.15.1 Business Overview
15.15.2 Product and Service Offerings
Chapter 16. Appendix
16.1 Sources and References
16.2 Related Reports
Want a report tailored exactly to your business need?
Request CustomizationEmpowering Leaders Across the Globe
Leading companies across industries trust us to deliver data-driven insights and innovative solutions for their most critical decisions. From data-driven strategies to actionable insights, we empower the decision-makers who shape industries and define the future. From Fortune 500 companies to innovative startups, we are proud to partner with organisations that drive progress in their industries.
Working with P&S Intelligence and their team was an absolute pleasure – their awareness of timelines and commitment to value greatly contributed to our project's success. Eagerly anticipating future collaborations.
McKinsey & Company
India
Our insights into the minutest levels of the markets, including the latest trends and competitive landscape, give you all the answers you need to take your business to new heights
We take a cautious approach to protecting your personal and confidential information. Trust is the strongest bond that connects us and our clients, and trust we build by complying with all international and domestic data protection and privacy laws
Customize the Report to Align with Your Business Objectives
Request the Free Sample Pages